Reduction of the soluble cyclic GMP vasorelaxing system in the vascular wall of stroke-prone spontaneously hypertensive rats: Effect of the α1-receptor blocker doxazosin

Journal of Hypertension

Volumn 20, Issue 3, 2002, Pages 463-470

  López Farré, Antonio ^a   Rodriguez Feo, Juan A ^a   García Colis, Elena ^a   Gomez, Juan ^a   López Blaya, Almudena ^a   Fortes, José ^a   De Andrés, Raimundo ^a   Rico, Luis ^a   Casado, Santos ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

Doxazosin; Endothelial dysfunction; Hypertension; Soluble guanylate cyclase; Vasorelaxation

Indexed keywords

ADRENERGIC RECEPTOR; CATECHOLAMINE; CYCLIC GMP; DOXAZOSIN; GUANYLATE CYCLASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; HYPERTENSION; MEAN ARTERIAL PRESSURE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SECOND MESSENGER; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0036492173     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200203000-00022     Document Type: Article

References (41)

1. The L-arginine-nitric oxide pathway
2. Regulation of vascular homeostasis by nitric oxide
3. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerine and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hychoxylamine
4. Alterations to L-arginine: The nitric oxide pathway in spontaneously hypertensive rats
5. Reduced basal NO-mediated dilation and decrease endothelial NO synthase expression in coronary vessels of spontaneously hypertensive rats
6. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan
7. Superoxide production risk factors and endothelium-dependent relaxation in human internal mammary arteries
8. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia
9. Endothelial cytosolic proteins bind to the 3′-untranslated region of endothelial nitric oxide synthase mRNA: Regulation by tumor necrosis factor alpha
10. Role of nitric oxide in antocrine control of growth and apoptosis of endothelial cells
11. Vasodilator dysfunction in aged spontaneously hypertensive rats: Changes in NO synthase III and soluble guanylyl cyclase expression and in superoxide anion production
12. Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: Role of enhanced vascular superoxide anion production
13. Soluble guanylate cyclase purified from bovine lung contains heme and copper
14. Expression of soluble guanylate cyclase activity requires both enzyme subunits
15. Antihypertensive therapy augments endothelium-dependent relaxations in coronary arteries of spontaneously hypertensive rats
16. A compression of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension a multicenter study
17. Structure and function of resistance arteries of hypertensive patients treated with a β-blocker or a calcium channel antagonist
18. The effects of epinephrine on norepinephine release in essential hypertension
19. Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings
20. The cardiovascular effects of alpha-receptor blocking
21. Alpha-adrenergic blockers: Mechanism of action, blood pressure control, effects of lipoprotein metabolism
22. Plasma catecholamines and neuropeptide-Y as indices of sympathetic nerve activity in normotensive and stroke-prone spontaneously hypertensive rats
23. Doxazosin: An update of its pharmacology and therapeutic application in hypertension and benign prostatic hyperplasia
24. Mechanisms of the endothelial toxicity of cyclosporine A (CyA)
25. Expression of constitutive and inducible nitric oxide synthases in vascular wall of young and aging rats
26. Change of structual proteins during the assembly of the head of bacteriophage T4
27. Expression of endothelial nitric oxide synthase in human peritoneal tissue: Regulation by E. coli lipopolysacharide
28. Effects of aspirin on platelet-neutrophil interactions: Role of nitric oxide and endothelin-1
29. Analysis of the genetic basis of the endothelium-dependent impaired vasorelaxation in the stroke-prone spontaneously hypertensive rats: A candidate gene approach
30. Regulation of vascular smooth muscle soluble guanylate cyclase activity, mRNA and protein levels by cAMP-elevating agents
31. AAMP regulates soluble guanilate cyclase beta 1-subunit gene expression in RFL-6 rat fetal lung fibroblasts
32. Nerve growth factor decreases soluble guanylate cyclase in rat pheochromocytoma PC12 cells
33. Hypercholesterolemic decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase
34. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
35. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
36. Nitric oxide synthase expression in the course of lead-induced hypertension
37. Superoxide anion production is increased in a model of genetic hypertensnhoutte ion: Role the endothelium
38. Endothelium-derived relaxing, contracting and hyperpolarizing factors of mesenteric arteries of hypertensive and normotensive rats
39. An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice
40. Effect of doxazosin on endothelial dysfunction in hypercholesterolemic/antioxidant-deficient rats
41. Phosphodiesterase inhibition improves agonist-induced relaxation of hypertensive pulmonary arteries